GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » Other Operating Expense

Pharma Mar (XMAD:PHM) Other Operating Expense : €10.3 Mil (TTM As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar Other Operating Expense?

Pharma Mar's Other Operating Expense for the three months ended in Mar. 2024 was €2.4 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was €10.3 Mil.

Pharma Mar's quarterly Other Operating Expense increased from Sep. 2023 (€2.4 Mil) to Dec. 2023 (€2.7 Mil) but then declined from Dec. 2023 (€2.7 Mil) to Mar. 2024 (€2.4 Mil).

Pharma Mar's annual Other Operating Expense increased from Dec. 2021 (€9.1 Mil) to Dec. 2022 (€11.6 Mil) but then declined from Dec. 2022 (€11.6 Mil) to Dec. 2023 (€11.5 Mil).


Pharma Mar Other Operating Expense Historical Data

The historical data trend for Pharma Mar's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Other Operating Expense Chart

Pharma Mar Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.61 10.47 9.13 11.58 11.53

Pharma Mar Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.61 2.74 2.44 2.73 2.37

Pharma Mar Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €10.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharma Mar Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Mar (XMAD:PHM) Business Description

Traded in Other Exchanges
Address
Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Pharma Mar (XMAD:PHM) Headlines

From GuruFocus

Q2 2020 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2022 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2019 PulteGroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2019 PulteGroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2020 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2022 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q1 2021 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024